j&j
J&J, AbbVie cancer drug significantly slows progression of rare lymphoma: study
By Michael Erman (Reuters) – Johnson & Johnson and AbbVie’s
J&J sues to block sales of ‘dangerous’ counterfeit HIV drugs
By Brendan Pierson (Reuters) – Johnson & Johnson has filed
J&J unit proposes independent exam if it remains in bankruptcy
By Dietrich Knauth, Tom Hals and Mike Spector – A
J&J tried to get federal judge to block publication of Reuters story
By Maria Chutchian and Tom Hals – Johnson & Johnson